drugset / Trial / NCT00764387

Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.

NCT00764387

Phase 4 Completed 166 enrolled Bayer
RandomizedParallel-groupSingle-blindDiagnostic

Summary

Study to compare of two contrast agents in imaging brain lesions.

Timeline

Start
2008-03
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadobutrol Diagnostic / imaging agent 0.1 unknown Intravenous
Comparator Gadoterate meglumine Diagnostic / imaging agent 0.1 unknown Intravenous